MARK W. KROLL - 15 Aug 2022 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role: Director
Signature: /s/ Thomas V. Powers, attorney-in-fact for Dr. Kroll
Issuer symbol: HAE
Transactions as of: 15 Aug 2022
Transactions value $: -$590,859
Form type: 4
Filing time: 16 Aug 2022, 16:33:56 UTC
Previous filing: 08 Aug 2022
Next filing: 08 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HAE	Common Stock	Sale	-$591K	-8.02K	-33.06%	$73.71	16.2K	15 Aug 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.41 to $74.25, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	This number includes unvested restricted stock units previously reported.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.41 to $74.25, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This number includes unvested restricted stock units previously reported.